automation
automation
Revolutionizing Biomanufacturing: Data Management is Key
📊 Biomanufacturing must rethink data management to keep up with the increasing complexity and volume of data generated in the industry. 🏭
Revolutionizing Cell Culture Automation with Raman Spectroscopy
🔬 Discover how Raman spectroscopy revolutionizes biopharmaceutical manufacturing by optimizing processes, improving quality, and reducing costs. 🧪✨
Boost Productivity & Cut Costs: Power of Digitization and Automation
🔍 Implementing a Digitization and Automation Strategy: Reduce costs and increase productivity with digitalization and automation! Roche's success story. 🚀🔬🤖
Revolutionary Automation System Cuts Cell and Gene Therapy Costs by 70
🤖 Vendor-agnostic automation system for cell and gene therapy manufacturing reduces errors and lowers costs.💡
Robots and AI Revolutionize Cell and Gene Therapy Manufacturing!
🤖🔬 Researchers suggest that robots and AI can address manufacturing challenges in cell and gene therapy. ⬆️🌍 The industry is growing rapidly, requiring skilled personnel and increased production. 🤖🔬 Automation and AI can improve efficiency and reduce costs.
Biopharma Struggles with Single-Use Standardization
📰 Lack of Single-Use Standardization a Challenge for Biopharma: Industry struggles with flexibility, automation, and supplier dependency. 💊💼🔬
Revolutionizing Bioprocessing with IoT Innovation
🌐💡 The IoT can revolutionize bioprocessing by connecting devices and exchanging data, leading to more efficient experiments and automation. 🚀
Novartis Revolutionizes Cancer Therapy Production with Automation
📢 Novartis automates new radioligand therapy plant in Indianapolis! Increased supply and timely production for prostate cancer therapy. 👨🔬🤖🏭💉
Cell and Gene Therapy: $82B Market by 2032 – Trends Challenges and Innovations
📰 The global cell and gene therapy market is expected to reach $82.24 billion by 2032, with a current size of $15.54 billion in 2022. - Precedence Research 🧫 🔬 Gene therapy is seeing a rise in gene editing therapeutics, but cost and access remain challenges. 💉 📈 Autologous CAR-T cell therapies are moving to earlier treatment stages, while allogeneic cell therapies and solid tumor therapies are being developed. 🤖 💼 Collaboration and flexible regulatory pathways are key to advancing the industry and delivering therapies to patients. 💪
Supercharge Vaccine Development with Automation and Collaboration
🧪 Recombinant protein vaccines are safe, effective, and easy to store, making them a leading human vaccine technology. ⏰ Shortening the time from vaccine discovery to commercialization is crucial for better pandemic preparedness. 🤖 Automation and digitalization can speed up vaccine development. 👥 Collaboration and open access platforms can facilitate knowledge sharing and ensure global access to vaccines. 💪 Scalable biotech manufacturing facilities with modular and flexible technologies are essential for large-scale production. 🏭 CDMOs have become crucial in responding to vaccine production demands. 🌍 Ensuring stable supply chains and timely regulatory certifications is necessary for CDMOs.
